Ventures
-
All
19
-
Harvard Business School
6
-
Harvard College
1
-
Harvard Extension School
1
-
Harvard Faculty of Arts and Sciences
1
-
Harvard Graduate School of Arts and Sciences
2
-
Harvard Graduate School of Design
1
-
Harvard Kennedy School
1
-
Harvard Law School
2
-
Harvard Medical School
6
-
Harvard T.H. Chan School of Public Health
2
-
Harvard University
13
-
I'm a post-doc
1
-
Non-Harvard Affiliate
4
-
AbscoTx
AbscoTx injects image-guided therapy into tumors to educate the immune system to fight cancer locally and at metastatic sites.
-
Aldatu Biosciences
Advancing infectious disease diagnostics that facilitate society's collective response to global health emergencies.
-
Alvus Health INC
Alvus Health is developing a data-centric and automatic platform for target identification and drug discovery.
-
BioDevek
Improving clinical outcomes following internal surgeries using degradable biomaterials.
-
Breaking
Breaking Inc. is using synthetic biology to get rid of plastic waste.
-
Ilios Therapeutics
Combating neurodegenerative diseases through rationally-designed multi-functional small molecules.
-
InGel Therapeutics
Regenerative cell-therapy biotech aiming to treat people affected by blindness.
-
Kern Systems
Kern Systems is developing cheaper and faster DNA synthesis.
-
Kestrel Therapeutics
Discovering and developing new molecules to treat intractable cancers.
-
KiraGen Bio
Harnessing the power of AI-driven combinatorial gene editing to unlock the full potential of solid tumor CAR-T therapies.
-
Lightning Biotherapeutics
Sparking immune regeneration by harnessing the body’s inherent regenerative capacity to create novel therapeutics.
-
MabLab
Building five-in-one test strips to detect the five deadliest lacing agents in recreational drugs.
-
Manifold Bio
Designing tissue-specific medicines in living systems from the start by combining high-throughput in-vivo studies with AI-guided protein design.
-
Nucyrna Therapeutics
Nucyrna Therapeutics aims to redefine RNA-targeting therapeutics, starting in neurodegenerative diseases.
-
Promakhos Therapeutics
Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.
-
Revision Bio
Creating next-generation precision genome editing technologies.
-
Stratagen Bio
Transforming MRI scans into a tool for objective clinical decision-making and quantitative biomarker assessment.
-
Tectonic Therapeutic, Inc.
Transforming the discovery of novel drugs addressing targets in the GPCR family.
-
Vaxess Technologies
Developing a novel transdermal patch technology to transform home delivery of therapies and vaccines